FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

3326411000001105: Clarityn Allergy 10mg tablets (Schering-Plough Ltd) 21 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
26107301000001114 Clarityn Allergy 10mg tablets (Schering-Plough Ltd) 21 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
89274801000001117 Clarityn Allergy 10mg tablets (Bayer Plc) 21 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Clarityn Allergy 10mg tablets (Schering-Plough Ltd) 21 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Clarityn Allergy 10mg tablets (Schering-Plough Ltd) 21 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Clarityn Allergy 10mg tablets (Schering-Plough Ltd) 21 tablet Is a Loratadine 10mg tablets 21 tablet true Inferred relationship Existential restriction modifier
Clarityn Allergy 10mg tablets (Schering-Plough Ltd) 21 tablet Is pack of Clarityn Allergy 10mg tablets (Schering-Plough Ltd) false Inferred relationship Existential restriction modifier
Clarityn Allergy 10mg tablets (Schering-Plough Ltd) 21 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Clarityn Allergy 10mg tablets (Schering-Plough Ltd) 21 tablet Has active ingredient Piperidine derivative false Inferred relationship Existential restriction modifier
Clarityn Allergy 10mg tablets (Schering-Plough Ltd) 21 tablet Has active ingredient Loratadine false Inferred relationship Existential restriction modifier
Clarityn Allergy 10mg tablets (Schering-Plough Ltd) 21 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Clarityn Allergy 10mg tablets (Schering-Plough Ltd) 21 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Clarityn Allergy 10mg tablets (Schering-Plough Ltd) 21 tablet Legal category Pharmacy medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Clarityn Allergy 10mg tablets (Schering-Plough Ltd) 21 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Clarityn Allergy 10mg tablets (Schering-Plough Ltd) 21 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Clarityn Allergy 10mg tablets (Schering-Plough Ltd) 21 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Clarityn Allergy 10mg tablets (Schering-Plough Ltd) 21 tablet Has AMP Clarityn Allergy 10mg tablets (Schering-Plough Ltd) true Inferred relationship Existential restriction modifier
Clarityn Allergy 10mg tablets (Schering-Plough Ltd) 21 tablet Has specific active ingredient Loratadine true Inferred relationship Existential restriction modifier
Clarityn Allergy 10mg tablets (Schering-Plough Ltd) 21 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Clarityn Allergy 10mg tablets (Schering-Plough Ltd) 21 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start